These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19108617)

  • 41. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
    Neumann S; Eliseeva E; McCoy JG; Napolitano G; Giuliani C; Monaco F; Huang W; Gershengorn MC
    J Clin Endocrinol Metab; 2011 Feb; 96(2):548-54. PubMed ID: 21123444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum.
    Morgenthaler NG; Minich WB; Willnich M; Bogusch T; Hollidt JM; Weglöhner W; Lenzner C; Bergmann A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):73-9. PubMed ID: 14654252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.
    Laurent E; Van Sande J; Ludgate M; Corvilain B; Rocmans P; Dumont JE; Mockel J
    J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
    Minich WB; Lenzner C; Morgenthaler NG
    Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition.
    Ueda Y; Sugawa H; Akamizu T; Okuda J; Ueda M; Kosugi S; Ohta C; Kihou Y; Mori T
    Eur J Endocrinol; 1995 Jan; 132(1):62-8. PubMed ID: 7531576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 48. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
    van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
    J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calmodulin purified from human and porcine thyroids inhibits thyrotropin binding to porcine thyroid cells.
    Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A; Ozaki O; Ito K; Kurihara H
    Thyroid; 1997 Dec; 7(6):943-8. PubMed ID: 9459642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies.
    Minich WB; Lenzner C; Bergmann A; Morgenthaler NG
    J Clin Endocrinol Metab; 2004 Jan; 89(1):352-6. PubMed ID: 14715871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.
    Ludgate M; Perret J; Parmentier M; Gerard C; Libert F; Dumont JE; Vassart G
    Mol Cell Endocrinol; 1990 Oct; 73(1):R13-8. PubMed ID: 1981364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human monoclonal thyroid stimulating autoantibody.
    Sanders J; Evans M; Premawardhana LD; Depraetere H; Jeffreys J; Richards T; Furmaniak J; Rees Smith B
    Lancet; 2003 Jul; 362(9378):126-8. PubMed ID: 12867115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease.
    Watson PF; Ajjan RA; Phipps J; Metcalfe R; Weetman AP
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):577-81. PubMed ID: 10197071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells.
    Inoue M; Tawata M; Yokomori N; Endo T; Onaya T
    Thyroid; 1998 Nov; 8(11):1059-64. PubMed ID: 9848724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.